Volume: 74, Issue: 6, Pages: 826 - 826
Published: Aug 1, 2019
Abstract
We appreciate the comments by Baker and colleagues on our paper [(1)][1]. We described that empagliflozin ameliorates adverse cardiac remodeling, enhances systolic function, switches myocardial fuel utilization, and improves myocardial energetics in a nondiabetic heart failure (HF) model. Baker...
Paper Fields
Paper Details
Title
Reply
Published Date
Aug 1, 2019
Volume
74
Issue
6
Pages
826 - 826
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.